Dina is a director in 3i's venture capital healthcare team and specialises in medical devices and pharmaceutical companies. Previous to joining 3i she worked at Index Ventures. Key 3i investments with her involvement include, Arrow Therapeutics, Endosense, Microsulis, Novexel, and Oxagen. By training, Dina is a molecular biologist and graduated from Cambridge University. She has also carried out postdoctoral research at the Pasteur Institute, Brown University and the Fox Chase Cancer Centre.